How many clinical trials are there for BRVO - Branch Retinal Vein Occlusion?

PlainTrial tracks 3 US clinical trials for BRVO - Branch Retinal Vein Occlusion, of which 0 are currently recruiting.

Which interventions appear most often on BRVO - Branch Retinal Vein Occlusion trial records?

bevacizumab is the most-linked intervention name on BRVO - Branch Retinal Vein Occlusion records (2 trial links), followed by EYE201. Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for BRVO - Branch Retinal Vein Occlusion?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

BRVO - Branch Retinal Vein Occlusion: later-stage trial registry

Compiled by PlainTrial · August 8, 2026

A small indexed set (3 trials) with no open enrollment listed right now.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

Jump to phase mix → How counts are built

3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count

BRVO - Branch Retinal Vein Occlusion: 3 US clinical trials tracked, none currently recruiting.

BRVO - Branch Retinal Vein Occlusion is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Outlook Therapeutics, running 2 of these trials.

Enrollment posture brief

Registry condition brvo-branch-retinal-vein-occlusion

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Open-enrollment share among volume-matched conditions near BRVO - Branch Retinal Vein Occlusion

BRVO - Branch Retinal Vein Occlusion has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for BRVO - Branch Retinal Vein Occlusion on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

BRVO - Branch Retinal Vein Occlusion is recruiting below its size-band peers.

0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Indexed trials (enrollment closed)

3 total, page 1 of 1

ACTIVE NOT RECRUITING Phase 3 120 participants

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders

Outlook Therapeutics

NCT05112861

ACTIVE NOT RECRUITING Phase 1 38 participants

A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

EyeBiotech

NCT06664502

COMPLETED Phase 3 195 participants

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Outlook Therapeutics

NCT04516278

Phase Distribution

Phase	Trial count
Phase 1	1
Phase 3	2

Top Sponsors

Outlook Therapeutics 2 trials

EyeBiotech 1 trials

Named interventions

Most-linked intervention names on BRVO - Branch Retinal Vein Occlusion records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

bevacizumab Biological

2 trials

EYE201 Drug

1 trials

US sites by state

Facility locations filed on BRVO - Branch Retinal Vein Occlusion trials. A trial with sites in several states counts in each.

Maryland 3 trials

Illinois 3 trials

Texas 2 trials

Tennessee 2 trials

Pennsylvania 2 trials

Florida 2 trials

California 2 trials

Arizona 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this BRVO - Branch Retinal Vein Occlusion page

3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

No BRVO - Branch Retinal Vein Occlusion trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
Outlook Therapeutics sponsors the most BRVO - Branch Retinal Vein Occlusion trials on record, review their full trial history before evaluating a specific study. See Outlook Therapeutics's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This BRVO - Branch Retinal Vein Occlusion condition card totals 3 registered trials; most-linked intervention bevacizumab; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.